Table of contents

Research Article

• More immunotherapy for multiple sclerosis. (1 September, 1996)

  R A Hughes, B Sharrack
• Epidemiology of disabling neurological disease: how and why does disability occur? (1 September, 1996)

  D T Wade
• Extrapontine myelinolysis. (1 September, 1996)

  S Schimrigk, G Amoiridis
• Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis. (1 September, 1996)

  C Pozzilli, S Bastianello, T Koudriavtseva, C Gasperini, A Bozzao, E Millefiorini, S Galgani, C Buttinelli, G Perciaccante, G Piazza, L Bozzao, C Fieschi
• Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study. (1 September, 1996)

  M I Botez, T Botez-Marquard, R Elie, O L Pedraza, K Goyette, R Lalonde
• A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. (1 September, 1996)

  P Burbaud, L Wiart, J L Dubos, E Gaujard, X Debelleix, P A Joseph, J M Mazaux, B Bioulac, M Barat, A Lagueny
• Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. (1 September, 1996)

  J Honnorat, J C Antoine, E Derrington, M Aguera, M F Belin
• Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome. (1 September, 1996)

  C Y Li, P Xue, W Q Tian, R C Liu, C Yang
• A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. (1 September, 1996)

  L Bendtsen, R Jensen, J Olesen
• Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. (1 September, 1996)

  M Scerrati, R Roselli, M Iacoangeli, A Pompucci, G F Rossi
• Differences in cardiovascular responses to supine exercise and to standing after exercise in two clinical subgroups of Shy-Drager syndrome (multiple system atrophy). (1 September, 1996)

  G D Smith, C J Mathias
• David Livingstone (1813-73). (1 September, 1996)

  L F Haas
• Right temporofrontal cortex as critical locus for the ecphory of old episodic memories. (1 September, 1996)

  P Calabrese, H J Markowitsch, H F Durwen, H Widlitzek, M Haupts, B Holinka, W Gehlen
• Doctors' writing, and writings. (1 September, 1996)

  G D Perkin
• Multiple sclerosis in Australia: socioeconomic factors. (1 September, 1996)

  S R Hammond, J G McLeod, P Macaskill, D R English
• Brain and spinal cord MRI in motor neuron disease. (1 September, 1996)

  J W Thorpe, I F Moseley, C H Hawkes, D G MacManus, W I McDonald, D H Miller
• Deafness due to bilateral endolymphatic sac tumours in a case of von Hippel-Lindau syndrome. (1 September, 1996)

  G Kempermann, H P Neumann, R Scheremet, B Volk, W Mann, J Gilsbach, R Laszig
• Brain metastases from an unknown primary tumour: which diagnostic procedures are indicated? (1 September, 1996)

  M van de Pol, V C van Aalst, J T Wilmink, A Twijnstra
• Longus cervicis colli "myositis" (syn: retropharyngeal tendinitis) (1 September, 1996)

  J M Pearce
• Cholinesterase inhibition in Parkinson's disease. (1 September, 1996)

  M Hutchinson, E Fazzini
• Central diabetes insipidus: a complication of herpes simplex encephalitis. (1 September, 1996)

  A Canton, R Simo, J Mesa, C Molina, A Rovira, X Montalban